NDC 70771-1109

ezetimibe

Ezetimibe

ezetimibe is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cadila Healthcare Limited. The primary component is Ezetimibe.

Product ID70771-1109_6ea7296a-8994-4e11-8eea-e02b6022cacc
NDC70771-1109
Product TypeHuman Prescription Drug
Proprietary Nameezetimibe
Generic NameEzetimibe
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2017-08-09
Marketing CategoryANDA / ANDA
Application NumberANDA204331
Labeler NameCadila Healthcare Limited
Substance NameEZETIMIBE
Active Ingredient Strength10 mg/1
Pharm ClassesDecreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 70771-1109-0

1000 TABLET in 1 BOTTLE (70771-1109-0)
Marketing Start Date2017-08-09
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70771-1109-4 [70771110904]

ezetimibe TABLET
Marketing CategoryANDA
Application NumberANDA204331
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-08-09

NDC 70771-1109-3 [70771110903]

ezetimibe TABLET
Marketing CategoryANDA
Application NumberANDA204331
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-08-09

NDC 70771-1109-0 [70771110900]

ezetimibe TABLET
Marketing CategoryANDA
Application NumberANDA204331
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-08-09

NDC 70771-1109-9 [70771110909]

ezetimibe TABLET
Marketing CategoryANDA
Application NumberANDA204331
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-08-09

NDC 70771-1109-1 [70771110901]

ezetimibe TABLET
Marketing CategoryANDA
Application NumberANDA204331
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-08-09

NDC 70771-1109-5 [70771110905]

ezetimibe TABLET
Marketing CategoryANDA
Application NumberANDA204331
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-08-09

NDC 70771-1109-2 [70771110902]

ezetimibe TABLET
Marketing CategoryANDA
Application NumberANDA204331
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-08-09

Drug Details

Active Ingredients

IngredientStrength
EZETIMIBE10 mg/1

OpenFDA Data

SPL SET ID:de814dcd-4759-4e9c-a650-335fb885a79d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 349556

    • Pharmacological Class

    • Decreased Cholesterol Absorption [PE]
    • Dietary Cholesterol Absorption Inhibitor [EPC]

    NDC Crossover Matching brand name "ezetimibe" or generic name "Ezetimibe"

    NDCBrand NameGeneric Name
    0591-3713EzetimibeEzetimibe
    0615-8300EzetimibeEzetimibe
    0781-5690EzetimibeEzetimibe
    0904-6664EzetimibeEzetimibe
    0904-7103EzetimibeEzetimibe
    16714-813EzetimibeEzetimibe
    16729-433EZETIMIBEEZETIMIBE
    31722-628EZETIMIBEEZETIMIBE
    42291-314EzetimibeEzetimibe
    49884-228EzetimibeEzetimibe
    50090-2717EzetimibeEzetimibe
    50090-3087EzetimibeEzetimibe
    50090-3402EzetimibeEzetimibe
    50090-3422EzetimibeEzetimibe
    50090-3657EzetimibeEzetimibe
    50228-379EzetimibeEzetimibe
    50268-298EzetimibeEzetimibe
    51660-200EzetimibeEzetimibe
    59651-052EzetimibeEzetimibe
    60429-982EzetimibeEzetimibe
    60505-2945EzetimibeEzetimibe
    60687-284EzetimibeEzetimibe
    60687-373EzetimibeEzetimibe
    67877-490EzetimibeEzetimibe
    68382-773ezetimibeezetimibe
    68462-226EzetimibeEzetimibe
    69238-1154EzetimibeEzetimibe
    70518-1783EzetimibeEzetimibe
    70518-1927EzetimibeEzetimibe
    70771-1109ezetimibeezetimibe
    71205-145EzetimibeEzetimibe
    71335-0933EzetimibeEzetimibe
    63629-7413EzetimibeEzetimibe
    71205-277EzetimibeEzetimibe
    71335-1127EzetimibeEzetimibe
    70518-2262EzetimibeEzetimibe
    71335-1354EzetimibeEzetimibe
    21695-778ZetiaEzetimibe
    50090-0833ZetiaEzetimibe
    55154-5031ZetiaEzetimibe
    55154-5034ZetiaEzetimibe
    55154-5043ZetiaEzetimibe
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.